Taylor Carolyn E.
SEC insider (Form 3/4/5 filer). CIK 0001875324. Director at Tonix Pharmaceuticals Holding Corp. (TNXP). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in BERKELEY HEIGHTS, NJ.
Companies Taylor Carolyn E. has filed insider reports for
- Tonix Pharmaceuticals Holding Corp. (TNXP): Director
Taylor Carolyn E.
CIK: 0001875324
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tonix Pharmaceuticals Holding Corp.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 12, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
PurchaseDirect1.4K shares at avg. $10.55$15K - May 12, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
22.7K shares- - Aug 21, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
PurchaseDirect418 shares at avg. $36.03$15K - May 13, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
10K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Purchase | 1,415 | $10.55 | $14,928 | Direct |
| May 12, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 22,700 | - | - | Direct |
| Aug 21, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Purchase | 418 | $36.03 | $15,061 | Direct |
| May 13, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 10,000 | - | - | Direct |
1-4 of 4 transactions